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Abstract  In  the  pathophysiology  of  spinal  cord  injury,  the  secondary  biological  processes
involving  changes  in  gene  expression  become  more  important  day  a  day.  Within  these  changes,
the expression  of  different  micro  RNAs  has  been  involved  in  some  of  the  pathophysiological
processes  of  spinal  cord  injury.
There  are  several  studies  that  describe  the  transient  expression  of  micro  RNA  in  spinal  cord
injury, some  of  them  related  to  inﬂammation  and  apoptosis  and  others  to  functional  recovery
and regeneration.
Micro  RNA  may  be  a  potential  target  for  the  treatment  of  spinal  cord  injury,  modifying  the
processes  of  inﬂammation,  oxidation,  apoptosis,  functional  recovery  and  regeneration.
It is  necessary  to  continue  the  study  of  micro  RNAs  in  spinal  cord  injury,  as  well  as  the  iden-
tiﬁcation of  their  target  genes  and  signalling  mechanisms  involved  in  its  neurological  effects.
With this,  the  ultimate  goal  is  the  development  of  effective  and  safe  therapeutic  and  diagnostic
strategies  for  patients  with  spinal  cord  injury.
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Micro  ARN  y  su  papel  en  la  ﬁsiopatología  de  la  lesión  medular;  un  paso  más  hacia  la
medicina  neurorregenerativa
Resumen  Dentro  de  la  ﬁsiopatología  de  la  lesión  medular,  cada  día  se  da  más  importancia  a
los procesos  biológicos  secundarios,  con  la  participación  de  cambios  en  la  expresión  genética.
Dentro de  estos  cambios,  la  expresión  de  diferentes  micro  ARN  ha  sido  involucrada  en  algunos
de los  procesos  ﬁsiopatológicos  de  la  lesión  medular.
Existen  diversos  estudios  que  describen  la  expresión  temporal  de  micro  ARN  en  la  lesión  medu-
lar, algunos  de  ellos  relacionados  con  la  inﬂamación  y  la  apoptosis,  y  otros  con  la  recuperación
funcional  y  la  regeneración.
Estos  micro  ARN  pueden  ser  blancos  potenciales  para  el  tratamiento  de  la  lesión  medular,  al
intervenir  en  los  procesos  de  inﬂamación,  oxidación  y  apoptosis,  y  en  la  recuperación  funcional
y regeneración.
Resulta  necesario  continuar  con  el  estudio  de  los  micro  ARN  en  la  lesión  medular,  así  como
la identiﬁcación  de  sus  genes  blanco  y  los  mecanismos  de  sen˜alización  que  participan  en  sus
efectos neurológicos.  Con  esto,  el  objetivo  ﬁnal  será  el  desarrollo  de  estrategias  terapéuticas
y diagnósticas  eﬁcaces  y  seguras  para  los  pacientes  con  lesión  medular.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Publicado  por  Masson  Doyma  México  S.A.  Este  es
un artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/
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Background
The  crucial  role  played  by  the  spinal  cord  in  a  wide  range  of
physiological  functions  is  clearly  demonstrated  by  the  deﬁcit
seen  after  a  spinal  cord  injury,  and  by  the  medical  conditions
which  develop  in  the  various  subsequent  stages.  This  injury
usually  results  in  devastating  neurological  changes  and  dis-
ability,  which  causes  not  only  the  loss  of  sensory  and  motor
capacity  (paraplegia  or  tetraplegia),  but  also  other  common
problems  associated  with  spinal  cord  injury  such  as:  urinary
complications,  gastrointestinal  problems,  cardiorespiratory
dysfunction  and  musculoskeletal  deformities.1,2 On  a  global
level,  it  principally  affects  men  between  the  ages  of  18--32,
with  an  estimated  incidence  of  23  cases  per  million,  of  trau-
matic  spinal  injury  (1,79,312  cases  per  year),  with  a  bimodal
peak  incidence  in  young  adults  (20--29  for  men  and  15--19  for
women),  and  elderly  adults  (men  over  70  and  women  over
60).2
There  are  2  main  damage  mechanisms  in  spinal  cord
injury,  namely:  primary  mechanical  damage  and  sec-
ondary  damage  caused  by  numerous  biological  processes
which  include  extensive  temporary  changes  in  genetic
expression.3,4 Secondary  damage  includes  inﬂammation,
oxidation  and  apoptosis,3 and  as  a  consequence,  the  for-
mation  of  a  glial  scar  which  acts  as  both  a  physical  and
a  molecular  barrier  to  axonal  regeneration.5 However,  it
has  been  demonstrated  that  astrogliosis  also  plays  a  key
role,  as  it  restores  subsequent  homeostasis  to  the  spinal
cord  injury,  by  promoting  repair  of  the  haematoencephalic
barrier  and  limiting  the  inﬁltration  of  inﬂammatory  cells.6,7
The  beneﬁcial  effect  of  astrogliosis  has  been  found  in  early,
hypertrophic  stages,  while  later,  hyperplastic  stages  result
in  the  formation  of  a  dense  scar  which  hinders  axonal
regeneration.8,9Furthermore,  it  has  been  demonstrated  that  apoptosis
not  only  affects  the  neurons  but  also  other  spinal  cord  cells,
such  as  the  microglial  cells.6 The  loss  of  oligodendrocytes
in  the  white  matter  tracts  continues  weeks  after  spinal
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9ord  injury,  and  might  contribute  to  progressive  demyelation
fter  the  injury.10,11
It  has  been  demonstrated  that  a  change  in  the  expres-
ion  of  various  genes  plays  a  major  role  in  the  pathogenesis
f  secondary  spinal  cord  injury.3,4 However,  little  is  known
bout  the  mechanisms  which  regulate  changes  in  the  expres-
ion  of  these  genes.  Micro  RNAs  are  attractive  candidates
s  ‘‘upstream’’  regulators  of  the  secondary  progression  of
pinal  cord  damage,  as  they  can  regulate  complete  series  of
enes  post-translationally.11--13 Various  forms  of  micro  RNA
ave  been  found  in  the  central  nervous  system  of  mammals,
hich  includes  the  brain  and  the  spinal  cord,  where  they
lay  an  essential  role  in  neurodevelopment  and  seem  to  be
mportant  mediators  of  neuronal  plasticity.14,15 Some  micro
NAs  have  even  been  involved  in  severe  neurological  dis-
ases  such  as  Tourette’s  and  Fragile  X  syndrome.16 Some
tudies  have  suggested  the  possibility  that  micro  RNAs  are
nvolved  in  neurodegeneration.17,18 However,  as  yet  the  role
f  micro  RNAs  in  spinal  cord  injury  has  been  little  studied,15
espite  the  fact  that  the  expression  of  a  great  many  micro
NAs  has  been  demonstrated  in  the  spinal  cords  of  adult
ice.13
There  follows  a  brief  review  of  the  relationship  between
pinal  cord  injury  and  micro  RNAs.
xpression of micro RNA in spinal cord injury
emporary  expression  of  micro  RNA  in  spinal  cord
njury
iu  et  al.15 carried  out  an  experiment  in  rats  with  traumatic
pinal  cord  injury  to  establish  the  temporary  expression  of
icro  RNAs.  The  authors  managed  to  demonstrate  that  aat’s  spinal  cord  contains  approximately  77%  (269)  of  the
icro  RNA  identiﬁed  in  mature  rats  (350),  which  suggests
hat  the  spinal  cord  is  a  rich  source  of  micro  RNA.  Of  these,
7  changed  in  a  statistically  signiﬁcant  way  after  the  spinal
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ord  injury.  Thus,  60  were  expressed  in  moderate,  high  and
ery  high  levels,  and  were  classiﬁed  into  5  different  groups.
roups  A  and  C  contained  upregulated  micro  RNAs,  group
 contained  downregulated  micro  RNAs  and  groups  B  and  E
ontained  micro  RNA  upregulated  4  hours  after  the  injury,
nd  subsequently  downregulated  1  and  7  days  after  the
njury.  The  remaining  37  micro  RNAs  expressed  at  a  low  level
nd  were  inhibited  after  the  injury.
As  decompression  of  the  spinal  cord  is  the  main  surgical
ption,  Ziu  and  co-authors19 carried  out  a  study  to  analyse
he  spatial  and  temporary  expression  of  the  levels  of  dif-
erent  micro  RNAs  and  their  relationship  with  the  duration
f  compression.  These  researchers  managed  to  demonstrate
hat,  depending  on  the  compression  time,  the  temporary
xpression  of  some  micro  RNAs  is  different.  In  particular,
iR-107  over-regulates  in  a  prolonged  compression  model,
hereas  its  levels  do  not  vary  in  a  short  compression  model.
hey  found  that  the  expression  of  miR-148  over-regulated  3
nd  6  hours  after  the  injury  in  prolonged  compression,  and
fter  6  hours  in  short  compression.  Finally  they  found  that
iR-210  over-regulates  after  3,  6  and  24  hours  in  the  pro-
onged  compression  model  and  only  after  24  hours  when  the
ompression  is  of  short  duration.
icro  RNAs  associated  with  inﬂammation  and
poptosis
n  turn,  Sahni  and  co-authors9 carried  out  an  experiment
n  mice  with  spinal  cord  injury  to  establish  the  role  of
one  morphogenetic  proteins  (BMPs)  and  their  receptors  in
strogliosis  secondary  to  spinal  cord  injury.  These  authors
anaged  to  demonstrate  a  signiﬁcant  increase  in  BMP4  lev-
ls  4,  7,  and  15  days  after  the  injury.  They  also  found  a
odest  increase  in  BMP7  levels  4  days  after  injury,  and  a
eturn  to  the  baseline  after  7  days.  Together  with  these  ﬁnd-
ngs,  they  demonstrated  an  increase  in  the  transcription  of
MP  receptor  1A  (BMPR1a)  and  of  glial  ﬁbrillary  acidic  pro-
ein  (GFAP)  4  and  7  days  after  the  injury.  The  BMP  signalling
oute  involves  SMAD  proteins,  and  it  has  been  demonstrated
hat  these  proteins  control  the  post-transcriptional  process-
ng  of  micro  RNA-21  (miR-21).17 In  relation  to  this,  Sahni  and
o-authors9 studied  the  behaviour  of  this  micro  RNA  in  their
ice.  They  managed  to  demonstrate  that  BMPR1a  signalling
egulates  the  cytoplasmatic  processing  of  miR-21  in  a  nega-
ive  way,  such  that  the  ﬁnal  processed  product  of  this  micro
NA  is  usually  inhibited  in  spinal  cord  injury.  Subsequently,
halala  et  al.20 performed  an  experiment  in  transgenic  mice
n  order  to  understand  the  role  of  miR-21  in  astrocytic
esponse  after  spinal  injury.  In  order  to  do  this,  they  gen-
rated  mice  with  over-expression  of  the  primary  transcript
f  miR-21  in  astrocytes  with  a  micro  RNA  sponge  designed
o  inhibit  the  function  of  miR-21.  The  authors  demonstrated
hat  after  traumatic  spinal  cord  injury,  the  over-expression
f  miR-21  in  astrocytes  attenuates  the  hypertrophic
esponse,  while  the  expression  of  the  sponge  increases  the
ypertrophic  phenotype,  even  in  chronic  stages.  They  also
ound  that  the  inhibited  function  of  miR-21  is  accompanied
y  an  increase  in  axonal  density  in  the  site  of  the  injury.  With
hese  results,  the  authors  managed  to  demonstrate  a  new
ffect  of  miR-21  in  the  regulation  of  astrocytic  hypertrophy
nd  the  progression  of  glial  scarring  after  spinal  cord  injury.
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Also  as  part  of  the  inﬂammatory  process,  Izumi  and
o-authors21 focussed  on  the  expression  of  miR-223  and  man-
ged  to  demonstrate  a high  expression  of  this  micro  RNA
2  hours  after  spinal  cord  injury.  Moreover,  their  data  indi-
ate  that  miR-223  can  regulate  neutrophils  in  the  acute
tage  of  spinal  cord  injury.
With  regard  to  apoptosis,  Liu  et  al.22 in  another  study,
emonstrated  a  signiﬁcant  change  in  the  expression  of  some
roapoptotic  micro  RNAs  in  rats  with  spinal  cord  injury;  in
act,  they  found  an  increase  in  the  expression  of  Let-7a  and
iR-16  10  days  after  the  injury,  and  a  reduction  in  the  levels
f  miR-15b.
icro  RNAs  associated  with  functional  recovery
nd regeneration
egeneration  refers  to  the  ability  to  reproduce  precise  repli-
as  of  lost  structures,  a  phenomenon  which  is  observed  in
ome  species  of  vertebrates,  such  as  salamanders,  axolotls
nd  zebraﬁsh,  but  lost  in  humans.  The  molecular  mecha-
isms  which  enable  this  process  remain  unknown.23 The  role
f  micro  RNAs  has  been  investigated  in  the  regeneration  of
he  spinal  cord  after  injury  in  some  of  these  species.
Sehm  and  co-authors23 performed  an  experiment  on
xolotls  to  determine  the  role  of  miR-196  in  the  regenera-
ion  of  the  tail,  after  it  had  been  amputated.  These  authors
emonstrated  a major  increase  in  the  expression  of  miR-
96  in  the  ﬁrst  14  days  after  the  amputation,  which  was
ot  maintained  subsequently.  Furthermore,  the  inhibition
f  miR-196  caused  signiﬁcant  defects  in  the  regeneration.
hese  data  suggest  that  this  micro  RNA  plays  a  key  role  in  the
rst  stages  of  regeneration  of  an  amputated  tail  in  axolotls.
With  this  same  species,  Díaz  Quiroz  and  co-authors24
ound  that  miR-125b  is  necessary  for  the  functional  recovery
f  spinal  cord  injuries.  In  fact,  these  authors  demonstrated
hat  the  reduction  of  miR-125b  in  axolotls  to  similar  levels
f  those  of  rats,  inhibits  regeneration  by  means  of  the  over-
egulation  of  an  ‘‘axonal  repellent’’  gene,  Sema4D,  which
nduces  the  formation  of  a  reminiscent  glial  scar.
Yu  et  al.25 for  their  part,  studied  the  role  of  miR-133b  in
unctional  recovery  after  spinal  cord  injury.  To  do  this,  they
sed  a  spinal  cord  injury  model  in  a  zebraﬁsh,  and  demon-
trated  an  upregulation  of  miR-133b  in  the  neurons  that
resented  regeneration  data  after  the  section  of  the  spinal
ord  and  the  inhibition  of  miR-133b  which  resulted  in  altered
otor  recovery,  as  well  as  decreased  axonal  regeneration.
otential targets of micro RNA in spinal cord
njury
nﬂammation,  oxidation  and  apoptosis
iu  et  al.15 analysed  the  role  of  micro  RNAs  after  spinal  cord
njury  by  investigating  potential  targets.  By  bioinformatic
nalysis  they  demonstrated  that  these  targets  are  genes
hich  code  for  components  involved  in  various  pathophys-ological  processes  such  as  inﬂammation,  oxidation  and
poptosis.  Diverse  inﬂammatory  genes  are  potential  targets
or  micro  RNAs  downregulated  after  spinal  cord  injury,
uch  as:  miR-122,  miR-181a,  miR-411,  miR-99a,  miR-34a,
Micro  RNA  and  its  role  in  the  pathophysiology  of  spinal  cord  inju
miR-30c,  miR-384-5p  and  miR-30b-5p.  On  the  other  hand,
several  anti-inﬂammatory  anti-oxidant  genes  are  potential
targets  for  RNA  micros  which  have  been  upregulated  after
spinal  cord  injury,  such  as:  miR-221,  miR-1,  miR-206,
miR-152  and  miR-214.  Some  apoptotic  genes  are  potential
targets  for  micro  RNAs  which  have  been  downregulated
after  spinal  cord  injury,  such  as:  miR-127,  iR-181a,  miR-411,
miR-34a  and  miR-384-5p.
These  ﬁndings  suggest  that  abnormal  expression  of  micro
RNAs  after  a  traumatic  spinal  cord  injury  might  con-
tribute  towards  the  pathogenesis  of  secondary  damage,  and
therefore  they  could  be  potential  targets  for  therapeutic
interventions  after  spinal  cord  injury.
Sahni  and  co-authors,9 for  their  part,  demonstrated  that
miR-21  negatively  regulates  the  reactive  hypertrophy  of
astrocytes  in  spinal  cord  injury.  However,  they  did  not  man-
age  to  determine  the  targets  of  miR-21  which  might  affect
the  size  of  these  cells,  and  therefore  they  suggest  that  fur-
ther  studies  should  be  carried  out  with  this  objective,  and
to  ﬁnd  possible  targets  for  therapeutic  intervention.
In  their  study  of  micro  RNAs  associated  with  apoptosis,
Liu  et  al.22 demonstrated  that  the  increase  in  the  expression
of  Let-7a  was  accompanied  by  an  increase  in  the  expression
of  RAS  and  MYC  10  days  after  the  injury;  however  31  days
afterwards,  the  expression  of  RAS  and  MYC  returned  to
baseline  levels,  despite  the  fact  that  the  expression  of
Let-7a  remained  elevated.  The  increase  in  the  expression  of
miR-16  was  associated  with  the  increase  in  the  expression
of  Bcl-2  (Fig.  1).
Furthermore,  it  has  been  demonstrated  that  exercise
after  spinal  cord  injury  maintains  muscle  mass  in  paralysed
limbs,26 stabilises  rhythmic  ﬁring  patterns  in  the  spinal
motor  neurons,27 stimulates  anatomical  and  biochemical
plasticity  in  the  spinal  cord28 and  produces  increased  levels
of  neurotrophic  factors  in  muscle  and  the  spinal  cord.29,30
This  is  why  Liu  et  al.22 studied  the  effect  of  exercise  on  the
expression  of  some  micro  RNAs.  These  authors  managed
to  demonstrate  that  5  days  of  exercise  after  spinal  cord
injury  were  accompanied  by  a  signiﬁcant  increase  in  the
expression  of  miR-21,  known  for  its  anti-apoptotic  effect,31
and  a  signiﬁcant  decrease  in  the  expression  of  miR-15b.
The  increase  in  the  expression  of  miR-21  was  accompanied
by  a  decrease  in  the  expression  of  PTEN  messenger  RNA
and  PDC4.  It  is  known  that  the  inhibition  of  these  proteins
RR
CD4 Cyclin D1RAS
MYC
Bim
BCL2
Bax/
Apoptosis
Caspase cascade
Let-7
miR15b
miR16 Bad
PTEN
PKB
miR21
PDCD4miR21
Figure  1  Relationship  between  the  different  micro  RNAs  with
their target  genes  in  apoptosis.
Adapted  with  the  permission  of  Liu  et  al.22
i
b
t
e
f
e
t
e
e
t
m
F
S
1
a
P
a
n
p
t
p
a
r
1
i
d
l
w
i
r
t
s
t
o
a
n
p
R
a
b
t
s
a
t
a
G
s
i
P
T
e
t
t
vry  445
s  associated  with  decreased  apoptosis  in  cancer  cells
y  inhibition  of  PKB.22 With  regard  to  the  decrease  in
he  expression  of  miR-15b,  a  paradoxical  increase  in  the
xpression  of  Bcl-2  associated  with  an  increase  of  Bcl-2  was
ound;  these  authors  found  a  signiﬁcant  decrease  in  the
xpression  of  mRNA  of  caspases  7  and  9.  Finally,  despite
he  fact  that  they  did  not  encounter  any  changes  in  the
xpression  of  Let-7a,  these  authors  demonstrated  that
xercise  signiﬁcantly  decreased  the  expression  of  RAS.  All
hese  changes  in  the  expression  of  micro  RNA  with  exercise
ight  explain  some  of  its  beneﬁcial  effects.
unctional  recovery  and  regeneration
ehm  and  co-authors23 studied  the  potential  targets  of  miR-
96  in  relation  to  tail  regeneration  in  the  axolotl.  These
uthors  showed  that  this  micro  RNA  acts  directly  on  the
ax7  gene  by  downregulating  levels  of  this  protein,  which
ffects  cell  division  during  regeneration  and  produces  a  phe-
otype  with  a  small  tail.  The  mechanism  of  this  protein  to
roduce  this  phenotype  was  by  using  a  feedback  loop  with
he  proteins  BMP4  and  Msx1,  known  for  their  control  in  cell
roliferation  in  the  spinal  cord.
Díaz  Quiroz  and  co-authors,24 after  identifying  miR-125  as
 major  factor  in  the  creation  of  an  environment  enabling
egeneration,  proved  the  effect  of  increased  levels  of  miR-
25b  in  rats  after  spinal  cord  injury.  In  order  to  do  so,  they
njected  a synthetic  miR-125b  into  the  site  of  the  injury  7
ays  after  the  trauma,  and  thus  demonstrated  decreased
evels  of  Sema4D  and  the  formation  of  glial  scarring,  as
ell  as  a  positive  effect  on  regeneration  with  signiﬁcantly
mproved  locomotion  in  some  animals.
In  their  study  on  the  role  of  miR-133b  in  functional
ecover  after  spinal  cord  injury,  Yu  et  al.25 demonstrated
hat  this  micro  RNA  is  important  in  the  regeneration  of  the
pinal  cord  of  the  adult  zebraﬁsh  by  reducing  the  levels  of
he  protein  RhoA,  a  small  GTPase.  The  activation  patterns
f  this  protein  have  been  studied  after  spinal  cord  injury,
nd  the  role  of  its  activation  on  apoptosis  in  the  central
ervous  system.32 Both  the  myelin-derived  growth  inhibitor
roteins  and  tumour  necrosis  factor  (TNF)  directly  activate
ho.  P75NTR (neurotrophin  receptor  p75)  activates  Rho  in  the
bsence  of  neurotrophin  binding.  The  inactivation  of  Rho
y  C3-05  (RhoA  antagonist)  after  spinal  cord  injury  blocks
he  elevation  of  p75NTR protein  levels  and  inhibits  apopto-
is.  The  inactivation  of  Rho  with  C3-05  prevents  apoptosis
nd  stimulates  regeneration.
MiR-133b  produces  this  reduction  by  its  direct  interac-
ion  with  RhoA  Messenger  RNA.  This  is  an  important  ﬁnding,
s  it  has  been  demonstrated  that  the  inactivation  of  this
TPase  results  in  rapid  recovery  of  locomotion  and  progres-
ive  recovery  of  coordination  between  front  and  rear  limbs
n  adult  mice.33
ossible  therapeutic  interventions
he  role  of  micro  RNAs  in  spinal  cord  injury  needs  to  be
xplored  further;  however,  every  day  there  is  more  evidence
o  suggest  that  these  micro  RNAs  represent  a  new  class  of
herapeutic  target.34--36 The  micro  RNA  in  the  central  ner-
ous  system  decreases  protein  levels  by  post-transcriptional
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246  
egulation.6,37 Thus  the  inhibition  of  a  micro  RNA  linked  to
 particular  disease  can  remove  the  block  of  expression  of
 therapeutic  protein.  Conversely,  the  administration  of  a
imetic  micro  RNA  can  stimulate  a  population  of  endoge-
ous  micro  RNA  which  in  turn  represses  a  harmful  gene.38 If
ts  small  size  and  the  current  knowledge  of  the  biogenesis  of
icro  RNAs  is  exploited,  some  modiﬁed  RNAs  could  be  used
emporarily  as  pre-processed  micro  RNAs  or  as  anti-micro
NA  oligonucleotides.39
Anti-micro  RNA  oligonucleotides  are  reverse-chain  com-
lementary  oligonucleotides.  Their  stability,  binding  afﬁn-
ty,  and  speciﬁcity  have  been  improved  by  chemical
odiﬁcation.  The  most  common  modiﬁcations  to  oligonu-
leotides  are  locked  nucleic  acids  (LNA),  2′-O-methyl,  and
hosphorothioate  skeletons.  Oligonucleotides  with  2′-O-
ethyl  modiﬁcation  have  been  demonstrated  to  be  effective
nhibitors  in  various  cell  lines  and  in  cultivated  primary
eurons.40--42 Recently,  oligonucleotides  modiﬁed  with  LNA
nd  phosphorothioate  against  miR-122  given  intravenously
o  mice  and  non-human  primates  has  resulted  in  a  lasting  and
ffective  reduction  in  plasma  cholesterol,  with  no  appar-
nt  toxicity.43 Oligonucleotides  modiﬁed  with  LNA  against
iR-122  (SPC3649)  are  currently  being  analysed  in  a  Phase
 study  on  hepatitis  C  virus  infection,  and  will  be  the  ﬁrst
herapeutic  target  with  micro  RNA  in  humans.44
The  imitators  of  micro  RNA  are  small  oligonucleotides,
enerally  double  chain,  and  chemically  modiﬁed  which  can
e  used  to  downregulate  speciﬁc  target  proteins.  The  dou-
le  chain  structure  is  necessary  for  efﬁcient  recognition  and
inding  to  RISC.  One  of  the  chains  is  mature  micro  RNA,  and
he  complementary  chain  forms  a  complex  with  the  mature
icro  RNA  sequence.36 Despite  the  fact  that  these  imitators
re  frequently  used  in  research  in  cultures,  there  are  still
o  in  vivo  data  to  demonstrate  the  efﬁcacy  of  micro  RNA
mitators.45
Many  challenges  are  yet  to  be  overcome  before  micro
NAs  are  used  as  therapeutic  targets,  namely:  their  difﬁcult
dministration,  possible  effects  on  other  systems  and  ensur-
ng  their  safety.  Nonetheless,  the  strategy  for  handing  micro
NAs  in  vivo  to  regulate  pathological  processes  is  becoming
 feasible  therapeutic  approach.  In  the  future,  a  greater
nderstanding  of  biogenesis  and  the  function  of  micro  RNAs
ill  doubtless  promote  the  development  of  micro  RNA-based
herapies.
onclusions
pinal  cord  injury  is  a  major  cause  of  disability  for  which
here  is  no  successful  treatment  as  yet.  A  study  of  micro
NAs  in  this  pathology  has  been  started,  which  has  shown
heir  importance  in  controlling  inﬂammation,  oxidation,
poptosis,  proliferation  and  regeneration.  It  is  necessary  to
ontinue  studying  micro  RNAs  in  spinal  cord  injury,  and  to
dentify  their  target  genes  and  the  signalling  mechanisms
hich  participate  in  their  neurological  effects.  Thus  the  ﬁnal
bjective  will  be  to  develop  effective  and  safe  therapeutic
nd  diagnostic  strategies  for  patients  with  spinal  cord  injury.onﬂict of interests
he  authors  have  no  conﬂict  of  interests  to  declare.
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